PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Clinical and bacteriological assessment of the ora³ preparation cefradoxil (duricef ? meyer, bristol)
Article published in Urologia Polska 1983/36/3.

authors

Tadeusz Krzeski, Józefa Wencel, Maciej Czaplicki
Klinika Urologiczna Instytutu Chirurgii Akademii Medycznej w Warszawie
Kierownik: prof. dr hab. med. Tadeusz Krzeski

summary

The assessment of the ora³ preparation from the group of cephalosporlns ? cefadroxil (Duricef) was based on the treatment of 33 patients with urinary tract infection*. Urine sterilization was achieved in 19 cases after 10 days of treatment. Reeurrence of infection develoiped in 4 cases. In 6 cases urine sterilization was not obtained but they had urinary tract changes favouring the development of infections. Duricef was well tolerated by the patients and effective in the treat­ment of urinary tract infections caused by bacteria sensitive to this drug.

references

  1. Bristol ? Myers Company. International Division: Cefadroxil, BMCID, 1981.
  2. Ginsburg C. M.: Clinical pharmacology of cefadroxil in infants and chil-dren. Antimicrob. Agents Chemother., 1978, 13, 845.
  3. Glen Lewis: Treatment of acute urinary tract infeictions with cefadroxil administered once daily. J. Int. Med. Res., 1980, 8, Supl. 1.
  4. Henness D., Richards D.: Clinical comparison of cefadroxil and cephalexin in uncoimplicated urinary tract infection. Current The-rapeutic Res., 1978, 23, 5.
  5. Leitner F.: Bactericidal activity of cefadroxil, cepha-lexin and -cephradine in an in vlitro phairmacakiinetic model: J. Antybiatics, 1979, 718, 3.
  6. McCracken G. H.: Pharmacokinetics of cefaclor in infants. J. Anti­microb. Chemother., 1978, 4, 882.
  7. Ripa S., Prenna M.: Laboratory studies with BL-S 578 (Cefadroxil), a new broadsipectrum orally active cephalosporin. Chemo-therapy., 1979, 25, 9.